Treatment to Prevent Hepatitis B Virus Reactivation in Patients With Lymphoma Receiving Chemotherapy

被引：2
|
作者：
Baang, Jihoon [1 ]
机构：
[1] Temple Univ, Dept Med, Sch Med, Philadelphia, PA 19140 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2015年 / 313卷 / 12期
关键词：
RESISTANCE; LAMIVUDINE; ENTECAVIR;
D O I：
10.1001/jama.2015.1438
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1269 / 1270
页数：2
相关论文
共 50 条
  • [1] Reactivation of Hepatitis B Virus in Patients Receiving Chemotherapy
    Ikeda, Masafumi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (01) : 8 - 16
  • [2] Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
    Chen, Kai-Lin
    Chen, Jie
    Rao, Hui-Lan
    Guo, Ying
    Huang, Hui-Qiang
    Zhang, Liang
    Shao, Jian-Yong
    Lin, Tong-Yu
    Jiang, Wen-Qi
    Zou, De-Hui
    Hu, Li-Yang
    Wirian, Michael Lucas
    Cai, Qing-Qing
    CHINESE JOURNAL OF CANCER, 2015, 34
  • [3] Optimal Antiviral Prophylaxis Against Hepatitis B Reactivation in Patients Receiving Rituximab-Based Chemotherapy for Lymphoma
    Abramson, Jeremy S.
    Chung, Raymond T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (23): : 2505 - 2507
  • [4] Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy
    Shiang Jiin Leaw
    Chia Jui Yen
    Wen Tsung Huang
    Tsai Yun Chen
    Wu Chou Su
    Chao Jung Tsao
    Annals of Hematology, 2004, 83 : 270 - 275
  • [5] Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy
    Leaw, SJ
    Yen, CJ
    Huang, WT
    Chen, TY
    Su, WC
    Tsao, CJ
    ANNALS OF HEMATOLOGY, 2004, 83 (05) : 270 - 275
  • [6] Management of hepatitis B reactivation in patients receiving cancer chemotherapy
    Huang, Yi-Wen
    Chung, Raymond T.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2012, 5 (05) : 359 - 370
  • [7] Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients
    Winnie Yeo
    Wing M. Ho
    Pun Hui
    Paul K. S. Chan
    Kwok C. Lam
    Jam J. Lee
    Philip J. Johnson
    Breast Cancer Research and Treatment, 2004, 88 : 209 - 215
  • [8] Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients
    Yeo, W
    Ho, WM
    Hui, P
    Chan, PKS
    Lam, KC
    Lee, JJ
    Johnson, PJ
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 (03) : 209 - 215
  • [9] Hepatitis B Virus Reactivation and Role of Antiviral Prophylaxis in Lymphoma Patients With Past Hepatitis B Virus Infection Who Are Receiving Chemoimmunotherapy
    Koo, Yu Xuan
    Tan, Daniel S. W.
    Tan, Iain B.
    Tao, Miriam
    Chow, Wan Cheng
    Lim, Soon Thye
    CANCER, 2010, 116 (01) : 115 - 121
  • [10] Clinical Profile and Efficacy of Antivirals in Hepatitis B Virus Reactivation, in Patients With Cancer Receiving Chemotherapy
    Wani, Manzoor A.
    Sodhi, Jaswinder S.
    Yatoo, Ghulam N.
    Shah, Altaf
    Geelani, Sajad
    Zargar, Showkat A.
    Gulzar, Ghulam M.
    Khan, Mushtaq
    Aziz, Sheikh A.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (06) : 590 - 598
12345